AISAP Cardio vs Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) integrates with a common Eko digital stethoscope and provides rapid results in approximately 15 seconds during routine physical exams, making it highly accessible for general practitioners. AISAP Cardio, while automating POCUS interpretation, still requires the user to perform an ultrasound, which is a more specialized skill than using a stethoscope. Therefore, ELEFT offers a lower barrier to entry and broader applicability in routine clinical settings.

AISAP Cardio offers a comprehensive cardiac diagnostic assessment, including the detection of various valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis) and detailed measurements like LVEF, ventricular dimensions, and atrial areas. ELEFT, while valuable for early detection of low ejection fraction, focuses on a single key indicator of heart failure. AISAP Cardio provides a broader and deeper clinical picture for diagnosis.

Both tools state that pricing is not publicly available and requires direct contact for a demo and specific pricing information. As both are enterprise solutions with undisclosed costs, it is not possible to determine which offers better value without specific pricing details or publicly available cost-effectiveness studies.

Eko Low Ejection Fraction Tool (ELEFT) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available, which are critical for healthcare enterprise adoption. While AISAP Cardio's description implies these are likely present for an FDA-cleared medical device, the explicit confirmation for ELEFT provides greater transparency and assurance for enterprise readiness. Both are cloud-based and integrate with existing clinical workflows.

Both tools demonstrate significant innovation in applying AI to cardiac care. AISAP Cardio innovates by automating comprehensive point-of-care ultrasound interpretation, making advanced diagnostics more accessible at the bedside. ELEFT innovates by integrating AI-powered low ejection fraction detection into a routine physical exam using a digital stethoscope, enabling widespread, non-invasive early screening for heart failure risk. Their innovations address different but equally important aspects of cardiac diagnostics.

Eko Health (Tool B) provides a more established and publicly accessible support infrastructure through its Help Center, offering FAQs, user manuals for its devices, and clear contact options. While AISAP (Tool A) mentions support as part of its offering, specific public documentation or a dedicated support portal is not as readily apparent.